ACUTE ONCOLOGY SERVICE MODELS Overview
Download
Report
Transcript ACUTE ONCOLOGY SERVICE MODELS Overview
ACUTE ONCOLOGY SERVICE MODELS
Dr Judith Carser
Consultant in medical oncology
Southern Health & Social Care Trust
Overview
AO workload projections
AO models in England
Merseyside & Cheshire experience and workload analysis
Clinical case examples
Projected AO workload
2006/07 - 273,000 unplanned cancer admissions = 750 admissions
per day in England1
Equates to 5 cancer admissions per trust per day on average
2008/09 average LoS varied for cancer related admissions between
5.1-10.1 days - potential saving of 566,000 bed days if every region
had the same LoS as average in the best performing regions 2
One day snapshot at combined cancer centre/acute hospital trust
reported 19% of all in patients had a cancer diagnosis3
Average Los for those admitted to oncology was shorter than for those
admitted to general medicine3
1NCEPOD
report 2008
Office.DoH:Delivering the Cancer Reform Strategy 2010
3Acute Oncology Service: assessing the need and its implications. Clin Oncol 2011 Mansour D et al
2National Audit
AO models in UK
Core principles of AO promote education, awareness and early access
to specialist oncology advice
Number and type of AO admissions variable and will reflect local
service configuration
AO models should be configured to best meet local needs and
integrate with existing services whilst identifying areas for development
Acute district general hospital vs. integrated cancer centre vs. stand
alone tertiary oncology service
Model I – comprehensive cancer centre
Yorkshire Cancer Network – 2.6 million, 8000 new patient episodes/yr.
Non-surgical oncology –St James Institute of oncology – local services
for Leeds and tertiary referral centre for region. Acute services on site
Six additional hospital trusts providing cancer unit services with mix of
resident and visiting oncologists
AOS developed independently in each cancer unit by the resident
oncology team
In Cancer centre – assessment unit staffed by ANPs and junior
doctors. Model requires 20PAs of consultant time to provide a 5 day
service – equivalent to 2 FTEs
Model II – An acute cancer unit model,
Whittington Health
Stand alone consultant medical oncologist, specialty doctor in
oncology, haematology consultant and 2 oncology CNS, admin support
Dedicated medical ward for oncology-related admissions with medical
oncologist responsible for inpatient care – admission guidelines
Daily AOT review offered of appropriate patients in outlying medical
wards / MAU
Electronic referral pathways – inbuilt audit trail and data gathering
capacity.
Electronic alerts for chemotherapy patients / fast track MUO clinics /
weekly CUP MDT / radiology flags
Model III – stand alone cancer centre
Merseyside and Cheshire Cancer network – population 2.3 million,
10,000 new patient episodes/yr.
Tertiary stand alone Cancer Centre – no acute services on site. Local
cancer services for Wirral
Nine satellite chemotherapy clinics, one satellite radiotherapy unit
AOS developed in all 7 acute trusts in 2010 (excluding IoM) to
complement existing service in St Helens and Knowsley NHS Trust
ANP-led Acute oncology assessment ward, CCC established 2013
Location of AOS within acute
trusts Merseyside & Cheshire
SORM
UHA
WTH
Key:
s
s
s
SHK
W&H
RLUH
CCC
COC
CCC – The Clatterbridge Cancer
Centre NHS FT
WTH – Wirral University Hospitals
NHS FT
UHA – University Hospital Aintree
NHS FT
SORM – Southport & Ormskirk NHS
Trust
RLUH – Royal Liverpool & Broadgreen
NHS Trust
W&H – Warrington & Halton NHS
Trust
SHK – St Helen’s and Knowsley NHS
FT
COC – Countess of Chester NHS
Trust
Model III – acute oncology services
Local AOS with visiting oncologists (at least 2 per unit), 5PAs of
consultant support provided per week. The AOS oncologists provide at
least one site specialised service at the same trust
At least 1 WTE acute oncology CNS, 0.6-1.0 WTE admin support
No inpatient oncology beds, no acute trust employed oncology nurses
AO service available mon-fri 9am – 5pm to review patients as necessary
and within one working day of referral
Local AO and CUP MDTs
Central 24hour chemotherapy triage at Cancer Centre
Comparison of projected (2005-6 data) vs. actual workload of AOS
throughout network (2010-11)
- NatCanSAT commissioned to provide analysis of potential annual AO
workload – HES, chemotherapy, radiotherapy data, Cancer Registry
Projected potential workload = 3,924 patients, overall average LoS 12.8 days
Type of admission
Average LOS days (range)
1.new cancers (17%)
11 (7.5-16.1)
2.complications of cancer treatments (40%)
9.1 (5.7-14.1)
3.complications of cancer (43%)
17.3 (10.2-23.5)
Network AO workload 2010-11
Actual workload = 3,031 new referrals to 7 teams (incomplete 12
months for 3 teams)
Average Los reduced by 3 days from 12.8 to 9.7 days representing
saving of over 9,000 bed days
Impact of AO intervention
Type of intervention
Major
•
•
% patients
•
•
•
•
Intermediate
•
•
•
Minor
•
•
n=1,403
major vs. intermediate intervention, p<0.05;
major vs. minor intervention p<0.05
Managing new cancers
(including MU0)
Managing complications of
chemo/radiotherapy
Organising diagnostic tests
Cancelling or preventing
unnecessary tests
Symptom management
Preventing admission
Referral to other teams
including cancer centre/other
hospitals
Psychological support
Communication to primary
oncologists/others
Supervising progress of
inpatients
Organising follow up
Wirral experience - AOS
Griffiths R et al Wirral University Hospitals NHS Foundation Trust
New cancer referrals– Royal Liverpool University Hospital AOS
2010-11
Seen by AOS
2010 - 2011
Number
Gender
135
Male
female
71 (53%)
64 (47%)
Median age in yrs (range)
73 (37-92)
Final
diagnosis
Malignancy undefined origin
cCUP
Lung
Breast
Upper/lower GI
Urology
Gynae
Other
32 (24%)
18 (14%)
40 (30%)
6 (4%)
14 (10%)
6 (4%)
7 (5%)
12 (9%)
Median
survival
Admission – death (95% CI)
Discharge – death (95% CI)
61 days (48-74)
37 days (20-54)
Deaths in hospital
27 (20%)
Systemic therapy
Radiotherapy
22 (16%)
12 (9%)
Impact of an AOS upon the management of
patients with MUO – Wirral University Hospital
experience
Non-AO Cohort
Endoscopy
18
AO Cohort
p=0.028
p=0.114
16
14
Radiology
12
p=0.037
10
8
16.9
13.1
6
Tumour
Markers
4
p<0.001
2
0
Non-AO Cohort
0
AO Cohort
2
3
4
5
Number of investigation requests per patient
Mean LoS for patients admitted during the
diagnostic phase
Griffiths RW. et al, abstract NCRI 2012
1
Mean number of investigations during the
diagnostic phase
Wirral University Hospitals NHS Foundation trust
Comparison of historical and AO cohort
at Wirral University Hospital
Definitive Therapy
14%
12%
10%
p=0.098
8%
11.5%
4%
4.3%
2%
27
Decision on Best
Supportive Care
6%
71
29
12
p=0.001
p<0.0001
Non-AO
Cohort
AO Cohort
0%
Non-AO Cohort
AO Cohort
Proportion of patients dying without a clear
decision on management
Griffiths RW et al abstract NCRI 2012
0
20
40
60
Time from Referral (days)
80
Average time from referral until definitive
treatment decision
Wirral University Hospitals NHS Foundation Trust
Local agreements
Each acute Trust responsible for developing their own AOS which best
meets local needs including geographical location, demographics,
specialist service provisions
Ongoing engagement between acute trust and tertiary Cancer Centre
Local AO and CUP MDTs
Local AO steering groups
Local teaching and staff education
Local policies and procedures for referrals and patient alerts
Network agreements
Required to meet National Cancer Peer Review measures for both
carcinoma unknown primary and acute oncology including:
AO induction packs
Network treatment and disease related complications protocol book
AO and CUP clinical network groups
Specialist regional CUP MDT
Network agreed pathways for MUO, brain metastases
AO e-learning module supported by University of Liverpool
Network audits e.g. MSCC, neutropenic sepsis
Agreed oncology registrations for all AO patients
Network agreed minimum data set
Clinical scenarios
Patient 1: 54-year-old woman with breast cancer is undergoing
adjuvant chemotherapy and develops nausea and dizziness. The
patient has a temperature of 38ºC and phones the chemotherapy
helpline for advice
Patient 2: 72-year-old man presents to ED generally unwell with
abdominal pain, nausea and weight loss. CT scan reveals multiple liver
metastases but no obvious primary cancer
Patient 3: 61-year-old woman with metastatic lung cancer presents
with increasing pain. Patient had been due to attend cancer centre for
radiotherapy but admitted acutely to local hospital
Summary
There is proof that AOS works (and saves money!)
An evolving service which must adapt to local requirements
A successful AOS requires ‘buy-in’ and commitment from all
Should be developed alongside existing visiting oncology services to
provide continuity of care / reduce time travelling for oncologists
Cancer unit oncologists vs. visiting oncologists with more time in unit
Team effort – service must be adequately staffed, resourced and
supported if it is to succeed and develop
References
The National Confidential Enquiry into Patient Outcomes and Death. For better, or worse? NCEPOD,
2008
National Chemotherapy Advisory Group. Chemotherapy Services in England: ensuring quality and
safety, 2009
Royal College of Physicians and Royal College of Radiologists. Cancer patients in crisis: responding
to urgent needs, 2012
Towards saving a million bed days: reducing length of stay through an acute oncology model of care
for inpatients diagnosed as having cancer, BMJ Qual Saf 2011: 20:718-724. King J et al.
What is the impact of a new acute oncology service in acute hospitals. Experience from the
Clatterbridge Cancer Centre and Merseyside and Cheshire Cancer Network, Clinical Medicine 2013,
Vol 13, No 6: 1-5. HL Neville-Webbe , JE Carser et al.
Acute oncology service: assessing the need and its implications.Clin Oncol (R Coll Radiol)
2011;23:168-173. Mansour D et al.